In:
Journal of the American Veterinary Medical Association, American Veterinary Medical Association (AVMA), Vol. 225, No. 3 ( 2004-08-01), p. 401-408
Abstract:
Objective —To determine the prognostic factors for
survival and tumor recurrence in dogs with cutaneous mast cell tumors (MCTs) in the perineal and inguinal
regions treated surgically with or without adjunctive radiation therapy, chemotherapy, or both. Design —Retrospective study. Animals —68 dogs. Procedure —Medical records of dogs with histologically
confirmed MCTs in the perineal region, inguinal region, or both treated surgically with or without
adjunctive radiation therapy, chemotherapy, or both were reviewed. Results —Mean tumor-free interval was 1,635 days
(median not reached), and 1- and 2-year tumor-free rates were 79% and 71%, respectively. Median survival
time was 1,111 days (mean, 1,223 days), and 1- and 2-year survival rates were 79% and 61%, respectively.
Factors that negatively influenced survival time were age at diagnosis, tumor recurrence, and treatment
with lomustine. Conclusions and Clinical Relevance —Results indicated
that dogs with MCTs in the inguinal and perineal regions, if appropriately treated, may have survival
times and tumor-free intervals similar to dogs with MCTs in other locations. ( J Am Vet Med Assoc 2004;225:401–408)
Type of Medium:
Online Resource
ISSN:
0003-1488
DOI:
10.2460/javma.2004.225.401
Language:
Unknown
Publisher:
American Veterinary Medical Association (AVMA)
Publication Date:
2004
detail.hit.zdb_id:
2904887-4
SSG:
22
Permalink